A. Uslu Et Al. , "Pleural Involvement Upon Relapse of Myeloma Responding to Daratumumab Plus Carfilzomib: A Case Presentation and Literature Review," CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21, no.3, 2021
Uslu, A. Et Al. 2021. Pleural Involvement Upon Relapse of Myeloma Responding to Daratumumab Plus Carfilzomib: A Case Presentation and Literature Review. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21, no.3 .
Uslu, A., CENGİZ SEVAL, G., Merter, M., DALVA, K., & BEKSAÇ, M., (2021). Pleural Involvement Upon Relapse of Myeloma Responding to Daratumumab Plus Carfilzomib: A Case Presentation and Literature Review. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21, no.3.
Uslu, Atilla Et Al. "Pleural Involvement Upon Relapse of Myeloma Responding to Daratumumab Plus Carfilzomib: A Case Presentation and Literature Review," CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21, no.3, 2021
Uslu, Atilla Et Al. "Pleural Involvement Upon Relapse of Myeloma Responding to Daratumumab Plus Carfilzomib: A Case Presentation and Literature Review." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21, no.3, 2021
Uslu, A. Et Al. (2021) . "Pleural Involvement Upon Relapse of Myeloma Responding to Daratumumab Plus Carfilzomib: A Case Presentation and Literature Review." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21, no.3.
@article{article, author={Atilla Uslu Et Al. }, title={Pleural Involvement Upon Relapse of Myeloma Responding to Daratumumab Plus Carfilzomib: A Case Presentation and Literature Review}, journal={CLINICAL LYMPHOMA MYELOMA & LEUKEMIA}, year=2021}